Skip to content
10-Q

Quarterly Report

Sarepta Therapeutics, Inc. SRPT

0001193125-25-269436

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 104.79M sh
Shares Diluted Q3 2025 · Sep 30, 2025 100.24M sh
Shares Diluted Q3 2025 · Sep 30, 2025 98.55M sh
Shares Diluted Q3 2025 · Sep 30, 2024 100.45M sh
Shares Diluted Q3 2025 · Sep 30, 2024 99.57M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $25.01M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $98.38M
Capex Q3 2025 · Sep 30, 2024 $98.87M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$336.69M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$297.83M
Short Term Investments Q3 2025 · Sep 30, 2025 $237.92M
Short Term Investments Q3 2025 · Dec 31, 2024 $251.78M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $613.08M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $1.1B
Cash And Equivalents Q3 2025 · Sep 30, 2024 $197.86M
Stockholders Equity Q3 2025 · Sep 30, 2025 $1.32B
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.36B
Stockholders Equity Q3 2025 · Mar 31, 2025 $1.14B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.53B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.22B
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.08B
Stockholders Equity Q3 2025 · Mar 31, 2024 $961.19M
Stockholders Equity Q3 2025 · Dec 31, 2023 $859.34M
Current Liabilities Q3 2025 · Sep 30, 2025 $921.43M
Current Liabilities Q3 2025 · Dec 31, 2024 $731.68M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.17B
Total Liabilities Q3 2025 · Dec 31, 2024 $2.44B
Current Assets Q3 2025 · Sep 30, 2025 $2.72B
Current Assets Q3 2025 · Dec 31, 2024 $3.07B
Total Assets Q3 2025 · Sep 30, 2025 $3.49B
Total Assets Q3 2025 · Dec 31, 2024 $3.96B
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.80
Eps Diluted Q3 2025 · Sep 30, 2025 −$4.37
Eps Diluted Q3 2025 · Sep 30, 2024 $0.34
Eps Diluted Q3 2025 · Sep 30, 2024 $0.78
Eps Basic Q3 2025 · Sep 30, 2025 −$1.80
Eps Basic Q3 2025 · Sep 30, 2025 −$4.37
Eps Basic Q3 2025 · Sep 30, 2024 $0.35
Eps Basic Q3 2025 · Sep 30, 2024 $0.80
Sga Expense Q3 2025 · Sep 30, 2025 $91.89M
Sga Expense Q3 2025 · Sep 30, 2025 $363.42M
Sga Expense Q3 2025 · Sep 30, 2024 $128.2M
Sga Expense Q3 2025 · Sep 30, 2024 $394M
Net Income Q3 2025 · Sep 30, 2025 −$179.95M
Net Income Q3 2025 · Sep 30, 2025 −$430.56M
Net Income Q3 2025 · Jun 30, 2025 $196.89M
Net Income Q3 2025 · Mar 31, 2025 −$447.51M
Net Income Q3 2025 · Sep 30, 2024 $33.61M
Net Income Q3 2025 · Sep 30, 2024 $76.19M
Net Income Q3 2025 · Jun 30, 2024 $6.46M
Net Income Q3 2025 · Mar 31, 2024 $36.12M
Operating Income Q3 2025 · Sep 30, 2025 −$103.39M
Operating Income Q3 2025 · Sep 30, 2025 −$288.2M
Operating Income Q3 2025 · Sep 30, 2024 $22.2M
Operating Income Q3 2025 · Sep 30, 2024 $56.4M
Revenue Q3 2025 · Sep 30, 2025 $370.04M
Revenue Q3 2025 · Sep 30, 2025 $1.49B
Revenue Q3 2025 · Sep 30, 2024 $429.77M
Revenue Q3 2025 · Sep 30, 2024 $1.15B